Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Sapporo Clinical Laboratory's PEG Ratio or its related term are showing as below:
TSE:9776'
s PEG Ratio Range Over the Past 10 Years
Min: 0.63 Med: 1.93 Max: 20.23
Current: 19
During the past 13 years, Sapporo Clinical Laboratory's highest PEG Ratio was 20.23. The lowest was 0.63. And the median was 1.93.
TSE:9776's PEG Ratio is not ranked
in the Healthcare Providers & Services industry.
Industry Median: 1.42
vs TSE:9776: 19.00
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Sapporo Clinical Laboratory (TSE:9776) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Sapporo Clinical Laboratory PEG Ratio Related Terms
Sapporo Clinical Laboratory PEG Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sapporo Clinical Laboratory PEG Ratio Competitor Comparison
For the Pharmaceutical Retailers subindustry, Sapporo Clinical Laboratory's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sapporo Clinical Laboratory PEG Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Sapporo Clinical Laboratory's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Sapporo Clinical Laboratory's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Sapporo Clinical Laboratory (TSE:9776) has a PEG Ratio of 17.54 as of Jul. 20, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Sapporo Clinical Laboratory and its competitors. This is 809% above median its historical median of 1.93. Over the past decade, Sapporo Clinical Laboratory's PEG Ratio has ranged from 0.63 to 20.23.
Is Sapporo Clinical Laboratory's PEG Ratio too high?
Sapporo Clinical Laboratory's current PEG Ratio of 17.54 is 809% above median its 10-year median of 1.93. Over the past 10 years, this metric has ranged from a low of 0.63 to a high of 20.23. The Healthcare Providers & Services industry median PEG Ratio is 1.42. Sapporo Clinical Laboratory's value of 17.54 is 1135.2% above this industry median. Overall, Sapporo Clinical Laboratory has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does Sapporo Clinical Laboratory's PEG Ratio compare to competitors?
Sapporo Clinical Laboratory's PEG Ratio of 17.54 can be compared against companies in the Healthcare Providers & Services industry. The industry median PEG Ratio is 1.42. Sapporo Clinical Laboratory's value of 17.54 is 1135.2% above this benchmark. Historically, Sapporo Clinical Laboratory's own PEG Ratio has ranged from 0.63 to 20.23 over the past decade. While the company's 10-year median is 1.93 vs. the industry median of 1.42, Sapporo Clinical Laboratory has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Healthcare Providers & Services company?
The median PEG Ratio among Healthcare Providers & Services companies is 1.42, based on 224 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sapporo Clinical Laboratory's current PEG Ratio of 17.54 is 1135.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Sapporo Clinical Laboratory and its competitors. For the Healthcare Providers & Services industry, the median PEG Ratio is 1.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sapporo Clinical Laboratory's current PEG Ratio is 17.54, which is 809% above median its own 10-year median of 1.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sapporo Clinical Laboratory stock overvalued right now?
Sapporo Clinical Laboratory (TSE:9776) has a current PEG Ratio of 17.54. The stock's GF Value™ is 円1,041.47, compared to a current price of 円1,960.00 — trading 88.2% above its estimated fair value. The current PEG Ratio is 17.54, which is 809% above median its 10-year median of 1.93 and 1135.2% above the Healthcare Providers & Services industry median of 1.42. Sapporo Clinical Laboratory's overall GF Score™ is 43/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Sapporo Clinical Laboratory (TSE:9776), the current PEG Ratio is 17.54 as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sapporo Clinical Laboratory (TSE:9776) Overvalued in 2026?
Based on GuruFocus' analysis, Sapporo Clinical Laboratory stock appears to be overvalued.
The current stock price of 円1,960.00 is trading 88.2% above its estimated GF Value™ of 円1,041.47.
Key valuation signals for TSE:9776:
PEG Ratio: 17.54 (809% above median its 10-year median of 1.93)
GF Value™: 円1,041.47 vs. price of 円1,960.00 (88.2% above fair value)
Industry Position: 1135.2% above the Healthcare Providers & Services median
No single metric tells the full story. See the TSE:9776 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sapporo Clinical Laboratory Inc. is a Japan based company engaged in offering clinical testing services. Its portfolio of services covers clinical examination, pathological examination, dispensing pharmacy, food hygiene environmental test, and radiation management. It is also engaged in the development of an integrated system for clinical testing.
43GF Score
Get the complete analysis for TSE:9776
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:9776 has been successfully added to your 
